CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Juvenal Tobin W Chief Commercial Officer | Shares withheld for taxes | −5,573 | $22.23 | $124K | 78,181 |
| 2025-03-04 | Juvenal Tobin W Chief Commercial Officer | Grant or award · Restricted Stock Units | +47,838 | 47,838 | ||
| 2025-03-04 | Juvenal Tobin W Chief Commercial Officer | Option exercise · Restricted Stock Units | −13,811 | 41,432 | ||
| 2025-03-04 | Stokes Frank Chief Financial Officer | Option exercise | +12,186 | 48,776 | ||
| 2025-03-04 | Stokes Frank Chief Financial Officer | Shares withheld for taxes | −5,448 | $22.23 | $121K | 43,328 |
| 2025-03-04 | Stokes Frank Chief Financial Officer | Grant or award · Restricted Stock Units | +47,838 | 47,838 | ||
| 2025-03-04 | Stokes Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −12,186 | 36,558 | ||
| 2025-02-20 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −8,046 | $26.70 | $215K | 35,319 |
| 2025-02-05 | BRADBURY DANIEL Director | Sale 10b5-1 | −5,017 | $28.17 | $141K | 0 |
| 2025-02-05 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,425 | $28.17 | $40K | 0 |
| 2025-02-05 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,425 | $28.17 | $40K | 0 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −556 | $27.51 | $15K | 81,248 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −285 | $27.51 | $8K | 71,301 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −267 | $27.51 | $7K | 60,780 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −85 | $27.51 | $2K | 5,175 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −85 | $27.51 | $2K | 5,169 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −85 | $27.51 | $2K | 5,169 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −85 | $27.51 | $2K | 5,169 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −399 | $28.65 | $11K | 80,849 |
| 2025-01-13 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −204 | $28.65 | $6K | 71,097 |
Page 25 of 45 · 897 trades